−47.21 M USD
0.00 USD
About Metsera, Inc.
Sector
CEO
Christopher Whitten Bernard
Headquarters
New York
Website
Founded
2022
FIGI
BBG01MJLWZG3
Metsera is a clinical-stage biopharmaceutical company that focuses on creating innovative therapies for obesity and metabolic conditions. The company advances a range of oral and injectable treatment options while integrating proprietary health technology tools for personalized care.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Metsera, Inc. stocks are traded under the ticker MTSR.
MTSR stock has risen by 3.92% compared to the previous week, the month change is a 3.92% rise, over the last year Metsera, Inc. has showed a 3.92% increase.
MTSR reached its all-time high on Jan 31, 2025 with the price of 28.87 USD, and its all-time low was 25.50 USD and was reached on Jan 31, 2025. View more price dynamics on MTSR chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track Metsera, Inc. financials in yearly and quarterly reports right on TradingView.
No, MTSR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MTSR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Metsera, Inc. stock right from TradingView charts — choose your broker and connect to your account.